ENVERIC BIOSCIENCES INC

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 29405E505 since 12/18/2024, largest first.

Filer	% of Class	Shares	Form	Filed
Armistice Capital, LLC 13G	10.0%	405,092	13G	8/14/2026 Event 6/30/2026
Armistice Capital, LLC	10.0%	405,092
Steven Boyd	10.0%	405,092
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Intracoastal Capital LLC 13G	4.99%	71,246	13G	2/2/2026 Event 1/27/2026
Mitchell P. Kopin	4.99%	71,246
Daniel B. Asher	4.99%	71,246
Intracoastal Capital LLC	4.99%	71,246
Ayrton Capital LLC 13G/A	2.9%	111,145	13G/A	8/13/2026 Event 6/30/2026
Ayrton Capital LLC	2.9%	111,145
Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B	2.9%	111,145
Waqas Khatri	2.9%	111,145
Lind Global Fund III LP 13G/A	1.4%	51,866	13G/A	8/14/2026 Event 6/30/2026
Lind Global Fund III LP	1.3%	49,366
Lind Global Partners III LLC	1.3%	49,366
Easton Jeff	1.4%	51,866
Braeden Lichti 13G/A	0%	0	13G/A	12/10/2025 Event 12/9/2025
Braeden Lichti	0%	0
Northstrive Fund II LP	0%	0
Northstrive Fund II LP 13G/A	0%	0	13G/A	12/10/2025 Event 12/9/2025
Northstrive Fund II LP	0%	0
Braeden Lichti	0%	0

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q2	23	527 k	$733 k	$0
2026 Q1	11	55.0 k	$107 k	$0
2025 Q4	11	24.2 k	$87.7 k	$0